An Israeli-led international study featured on the cover of The Journal of Neuroscience in February, holds the promise of advancing the field of cell-replacement therapy for people with Parkinson’s disease (PD).
PD, which affects millions of people worldwide, causes devastating motor symptoms due to a loss of dopamine-secreting brain cells (dopaminergic neurons). Although there is no cure for PD, its symptoms can be treated.